Medicaid to implement clinical edit for ADHD/ADD stimulants

The Mississippi Drug Utilization Review Board (DUR) has recommended that the Mississippi Division of Medicaid (DOM) implement prescribing guidelines for stimulant drugs most commonly used to treat attention deficit hyperactivity disorder (ADHD)/attention deficit disorder (ADD). In accordance with the DUR Board’s March 1, 2018, recommendations DOM will implement diagnosis edits concerning the use of stimulant drugs for both adults and … Continue reading Medicaid to implement clinical edit for ADHD/ADD stimulants